One in Every 28 Australians Are Diagnosed With Lung Cancer, Says Study

One in Every 28 Australians Are Diagnosed With Lung Cancer, Says StudyResearchers at the ARC Centre of Excellence for Free Radical Chemistry and Biotechnology at the Australian National University have claimed to discover a new compound that can play a role to manage a peptide hormone called calcitonin, which is believed to stimulate small cell lung cancer growth. In addition, the experts have revealed that the new way will regulate a hormone that stimulates cancer growth as well as new insight to control the feel-good hormone, oxytocin.

While commenting on the findings, the lead researcher Professor, Chris Easton, claimed to develop one compound in particular that slows down the products of calcitonin and therefore restricts cell growth and also selectively stops cancer growth.

In addition, Professor Chris Easton notified that one in every 28 Australians are diagnosed with lung cancer and marked it as the most common cause of cancer death and stressed on the need to develop new pharmaceuticals to treat this disease.

“Oxtytocin is the feel-good hormone and gives people a natural high. Most people have background levels of oxytocin. By studying more broadly how production of these peptide hormones is regulated and inter-related, we can look at stimulating the production of some hormones and reducing the levels of others”, added Professor Easton. “Some people have not enough oxytocin in regular levels, so they move from feelings of well-being to feeling down or depressed”.